Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gliadel Wafers for Recurrent Supratentorial Low Grade Glioma
NCT00003467Phase 2Completed
- Sponsor
- Duke University
- Start
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine in low-grade glioma (LGG), sponsored by Duke University. Started Jan 1998; status: completed.
02
Drugs
carmustine
03
Conditions
low-grade glioma (LGG)
Beyond the preview
Go deeper on NCT00003467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003467.